Cardiogenic shock differential diagnosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Syed Musadiq Ali M.B.B.S.[3] Ramyar Ghandriz MD[4]
Overview
Shock is a clinical syndrome resulting from the hypoperfusion of the tissues. Regardless of the underlying cause, this hypoperfusion leads to the failure to meet tissues' nutritional and oxygen needs, causing cellular dysfunction. The affected tissues lead to the production and release of inflammatory mediators that will further jeopardize perfusion through changes in the vasculature. The results of these changes are organ failure and death if treatment in not timely applied. According to the underlying cause, there will be different types of shock, which will have similar presentations. It is mandatory to determine the underlying cause of the condition so that proper treatment may be started. Cardiogenic shock is a clinical condition, defined as a state of systemic hypoperfusion originated in cardiac failure, in the presence of adequate intravascular volume, typically followed by hypotension, which leads to insufficient ability to meet oxygen and nutrient demands of organs and other peripheral tissues. It may range from mild to severe hypoperfusion and may be defined in terms of hemodynamic parameters, which according to most studies, means a state in which systolic blood pressure is persistently < 90 mm Hg or < 80 mm Hg, for longer than 1 hour, with adequate or elevated left and right ventricular filling pressures that does not respond to isolated fluid administration, is secondary to cardiac failure and occurs with signs of hypoperfusion (oliguria, cool extremities, cyanosis and altered mental status) or a cardiac index of < 2.2 L/min/m² (on inotropic, vasopressor or circulatory device support) or < 1.8-2.2 L/min/m² (off support) and pulmonary artery wedge pressure > 18 mm Hg.
Differential Diagnosis
Depending on the author and the source used there will be different ways of organizing the types of shock. Sometimes it might be difficult to differentiate, from the clinical standpoint, two types of shock since components of each type may combine in a single patient. The clinical presentation of shock is usually the result of a complexity of processes, such as the sympathetic and endocrine responses to hypoperfusion, along with manifestations of organ failure. Patients who present with signs and symptoms of hypoperfusion following a diagnosed or suspected myocardial infarction, are commonly suffering a cardiogenic shock as a complication of the MI. However, other clinical scenarios, not related to acute MI, may present similarly:[1][2]
-
- More than a simple loss of intravascular volume, hypovolemic shock is a dynamic process in which the responses to the initial insult, and the period of time during which they are in practice, will dictate the response to treatment and therefore the outcome. Several causes may be in the origin of this type of shock, including: hemorrhage, dehydration, GI or urinary losses and severe venodilation (in the setting of other conditions). There is a relationship between the clinical status of the patient and the amount of circulating blood volume, the signs may include pallor, cool extremities, tachycardia and tachypnea, oliguria and decreased consciousness. Compensatory mechanisms are responsible for tolerating initial blood loss, however they begin to fail after about 20-25% of blood has been lost. This tolerance will be dictated mostly by the previous cardiac reserve of the patient, along with the velocity of loss of intravascular volume[3][4].
- When comparing hypovolemic and cardiogenic shock (most commonly complicating acute-MI) some specific clinical signs of shock will be similar, however, others will be different, particularly signs of CHF, such as the presence of distended jugular and peripheral veins, presence of an S3 sound and pulmonary edema on the cardiogenic type.
- When comparing hemodynamic data, similarities include: decreased cardiac index, stroke volume index, cardiac output, mixed venous oxygen saturation and increased difference in arteriovenous O2 saturation and SVR. Differences to be noted include: decreased ventricular preload, ventricular diastolic volumes and pressures, pulmonary wedge pressure and central venous pressure.
- When treating hypovolemic shock it's mandatory to rule out cardiogenic cause because part of the treatment for hypovolemic shock, urgent intravascular volume replacement, may further jeopardize the cardiac condition in the cardiogenic form.
-
- This form of shock results from an obstruction to the flow of blood through the cardiovascular system, including the vessels and the heart. Therefore, different causes may give rise to this condition, such as: tension pneumothorax, pulmonary emboli, pericardial tamponade and constrictive pericarditis.[5] As in other types of shock, the clinical response will be heavily dictated by the timespan during which the insult develops and urgent therapy must be applied[6][7].
- To evaluate the hemodynamics of obstructive shock it is important to know the underlying etiology of the shock, since different causes will present with different hemodynamic values. One example of cause of obstructive shock is cardiac tamponade, which, similarly to the cardiogenic form, will likely present with: decreased cardiac index, stroke volume, stroke work, mixed venous oxygen saturation and increased difference in arteriovenous O2 saturation, right and left ventricular diastolic pressures, pulmonary artery diastolic pressure, serum lactate and CVP. Other causes may be observed on the table below.
-
- The hallmark of this form of shock is the decrease of peripheral resistance. This may be present in a series of conditions that may lead to distributive shock, such as: sepsis, anaphylaxis, toxic shock syndrome and adrenal crisis.
- When compared to cardiogenic shock it presents with similarities, such as: decreased cardiac index, left and right ventricular stroke work and increased serum lactate. The differences reside in: overall decreased of SVR, which after fluid resuscitation may become elevated, ventricular filling pressure, difference in arteriovenous O2 saturation and increase of mixed venous oxygen saturation. It is important to note that, unlike cardiogenic and other types of shock, in the distributive kind there is an increase in venous oxygen saturation which, despite the increased O2 demand, might be due to the increased total body perfusion, that is responsible for diminishing the effectiveness of individual tissue perfusion[8][9][10].
Type of Shock | Etiology | CO | SVR | PCWP | CVP | SVO2 | RVS | RVD | PAS | PAD |
Cardiogenic | Acute Ventricular Septal Defect | ↓↓ | ↑ | N — ↑ | ↑↑ | ↑ — ↑↑ | N — ↑ | ↑ | N — ↑ | N — ↑ |
Acute Mitral Regurgitation | ↓↓ | ↑ | ↑↑ | ↑ — ↑↑ | ↓ | ↑ | N — ↑ | ↑ | ↑ | |
Myocardial Dysfunction | ↓↓ | ↑ | ↑↑ | ↑↑ | ↓ | N — ↑ | N — ↑ | N — ↑ | ↑ | |
Right Ventricular Infarction | ↓↓ | ↑ | N — ↓ | ↑↑ | ↓ | ↓ — ↑ | ↑ | ↓ — ↑ | ↓ — ↑ | |
Obstructive | Pulmonary Embolism | ↓↓ | ↑ | N — ↓ | ↑↑ | ↓ | ↓ — ↑ | ↑ | ↓ — ↑ | ↓ — ↑ |
Cardiac Tamponade | ↓ — ↓↓ | ↑ | ↑↑ | ↑↑ | ↓ | N — ↑ | ↑ | N — ↑ | N — ↑ | |
Distributive | Septic Shock | N — ↑↑ | ↓ — ↓↓ | N — ↓ | N — ↓ | ↑ — ↑↑ | N — ↓ | N — ↓ | ↓ | ↓ |
Anaphylactic Shock | N — ↑↑ | ↓ — ↓↓ | N — ↓ | N — ↓ | ↑ — ↑↑ | N — ↓ | N — ↓ | ↓ | ↓ | |
Hypovolemic | Volume Depletion | ↓↓ | ↑ | ↓↓ | ↓↓ | ↓ | N — ↓ | N — ↓ | ↓ | ↓ |
The following table outlines the major differential diagnoses of Shock on the basis of clinical manifestations..[13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48]
Abbreviations: ABG (arterial blood gas); ACE (angiotensin converting enzyme); BMI (body mass index); CBC (complete blood count); CSF (cerebrospinal fluid); CXR (chest X-ray); ECG (electrocardiogram); FEF (forced expiratory flow rate); FEV1 (forced expiratory volume); FVC (forced vital capacity); JVD (jugular vein distention); MCV (mean corpuscular volume); Plt (platelet); RV (residual volume); SIADH (syndrome of inappropriate antidiuretic hormone); TSH (thyroid stimulating hormone); Vt (tidal volume); WBC (white blood cell); Coronary CT angiography (CCTA); multidetector row scanners (MDCT); Cardiovascular magnetic resonance — CMRI; Myocardial perfusion imaging (MPI); single-photon emission CT (SPECT); Positron emission tomography (PET) scanning; Magnetic resonance (MR) angiography, Computed tomographic (CT) angiography, and Transesophageal echocardiography (TEE), late gadolinium enhancement (LGE); right ventricular hypertrophy (RVH), right atrial enlargement (RAE), functional tricuspid regurgitation (TR), Pulmonary artery systolic pressure (PASP; adenosine deaminase (ADA); Serum amyloid A (SAA), soluble interleukin-2 receptor (sIL2R); High-resolution CT (HRCT) scanning
Differentials on the basis of Etiology | Disease | Clinical manifestations | Diagnosis | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Risk factors | Physical exam | Lab Findings | EKG | Imaging | Gold standard | |||||||||
Onset | Duration | Quality of Pain | Cough | Fever | Dyspnea | Weight loss | Associated Features | ||||||||
Myocardial Infarction[13][14][15][16] | Acute | Commonly > 20 minutes |
|
- | - | + | - |
|
|
|
|
| |||
Cardiac | |||||||||||||||
Aortic Dissection[49][50] | Sudden severe progressive pain (common) or chronic (rare) | Variable |
|
- | - | + | - |
|
|
|
|
|
| ||
Aortic intramural hematoma | Sudden severe progressive pain (common) or chronic (rare) | Variable |
|
- | - | + | - |
|
|
|
|
|
| ||
Penetrating atherosclerotic aortic ulcer[51][52][53] | Sudden severe pain | Variable |
|
- | - | + | - |
|
_ |
_ |
|
| |||
Pericardial Tamponade[54][55] | Acute or subacute | May last for hours to days |
|
+/- | + | + | - |
|
EKG findings:
|
|
|||||
Myocarditis[56][57][58] | Acute or subacute | Variable |
|
+/- | + | + | - |
|
|
|
|
||||
Hypertrophic cardiomyopathy[59][60][61] | Acute or subacute | Variable | Typical or atypical chest pain | - | - | + | - |
|
|
|
Non-specific |
|
|
Genetic testing for HCM | |
Stress (takotsubo) | Acute | Commonly > 20 minutes |
|
- | - | + | - |
|
Stress |
|
|
|
|||
Aortic Stenosis[66][67][68] | Acute, recurrent episodes of angina | 2-10 minutes |
|
- | - | + | - |
|
|
|
|
|
|||
Heart Failure[69][70][71] | Subacute or chronic | Variable |
|
+ | +/- | + | + | Dyslipidemia, hypertension, smoking, family history of premature disease, and diabetes |
|
|
|
||||
Differentials on the basis of Etiology | Disease | Clinical manifestations | Diagnosis | ||||||||||||
Symptoms | Risk factors | Physical exam | Lab Findings | EKG | Imaging | Gold standard | |||||||||
Onset | Duration | Quality of Pain | Cough | Fever | Dyspnea | Weight loss | Associated Features | ||||||||
Pulmonary | Pulmonary Embolism[72][73] | Acute | May last minutes to hours |
|
+ | +/- | + | - |
|
Hormone replacement therapy
Cancer Oral contraceptive pills Stroke Pregnancy Postpartum Prior history of VTE Thrombophilia |
|
|
|
||
Spontaneous Pneumothorax[74][75] | Acute | May last minutes to hours |
|
- | - | + | - |
|
|
|
|
|
| ||
Tension Pneumothorax[76][77] | Acute | May last minutes to hours |
|
- | - | + | - |
|
|
|
|
||||
Pleural Effusion[78][79][80] | Acute or subacute or chronic | Variable |
|
+ | +/- | + | +/- |
|
|
|
|
||||
Acute chest syndrome (Sickle cell anemia)[81][82][83] | Acute | May last minutes to hours |
|
+ | +/- | + | - |
|
|
|
|
|
--- | ||
Differentials on the basis of Etiology | Disease | Clinical manifestations | Diagnosis | ||||||||||||
Symptoms | Risk factors | Physical exam | Lab Findings | EKG | Imaging | Gold standard | |||||||||
Onset | Duration | Quality of Pain | Cough | Fever | Dyspnea | Weight loss | Associated Features | ||||||||
Gastrointestinal | Perforated Peptic Ulcer[84][85][86] | Acute |
|
|
+/- | - | - | +/- |
|
|
|
|
|
| |
Esophagitis[87][88][89] | Acute | Variable |
|
+ | + | - | +/- |
|
|
|
|||||
Esophageal Perforation[18] | Acute | Minutes to hours |
|
- | +/- | + | - |
|
|
|
|
|
| ||
Mediastinitis[90][91][92][93] | Acute, Chronic | Variable |
|
+/- | + | + | - |
|
|
|
|
|
|
CT scan | |
Pancreatitis[94][95][96][97][98] | Acute, Chronic | Variable |
|
- | + | + | +/- |
|
|
|
|
| |||
IBD | Acute, Chronic | Variable |
|
- | + | + | + |
|
|
|
|
|
|
|
References
- ↑ Longo, Dan L. (Dan Louis) (2012). Harrison's principles of internal medici. New York: McGraw-Hill. ISBN 978-0-07-174889-6.
- ↑ Parrillo, Joseph (2013). Critical care medicine principles of diagnosis and management in the adult. Philadelphia, PA: Elsevier/Saunders. ISBN 0323089291.
- ↑ Lier H, Bernhard M, Hossfeld B (March 2018). "[Hypovolemic and hemorrhagic shock]". Anaesthesist (in German). 67 (3): 225–244. doi:10.1007/s00101-018-0411-z. PMID 29404656.
- ↑ Kobayashi L, Costantini TW, Coimbra R (December 2012). "Hypovolemic shock resuscitation". Surg. Clin. North Am. 92 (6): 1403–23. doi:10.1016/j.suc.2012.08.006. PMID 23153876.
- ↑ "Shock: Shock and Fluid Resuscitation: Merck Manual Professional".
- ↑ Pich H, Heller AR (May 2015). "[Obstructive shock]". Anaesthesist (in German). 64 (5): 403–19. doi:10.1007/s00101-015-0031-9. PMID 25994928.
- ↑ Dababneh E, Siddique MS. PMID 28613734. Missing or empty
|title=
(help) - ↑ Smith N, Lopez RA, Silberman M. PMID 29261964. Missing or empty
|title=
(help) - ↑ Alyeşil C, Doğan NÖ, Özturan İU, Güney S (June 2017). "Distributive Shock in the Emergency Department: Sepsis, Anaphylaxis, or Capillary Leak Syndrome?". J Emerg Med. 52 (6): e229–e231. doi:10.1016/j.jemermed.2017.01.012. PMID 28238385.
- ↑ Brown SG (May 2007). "The pathophysiology of shock in anaphylaxis". Immunol Allergy Clin North Am. 27 (2): 165–75, v. doi:10.1016/j.iac.2007.03.003. PMID 17493496.
- ↑ Parrillo, Joseph E.; Ayres, Stephen M. (1984). Major issues in critical care medicine. Baltimore: William Wilkins. ISBN 0-683-06754-0.
- ↑ Judith S. Hochman, E. Magnus Ohman (2009). Cardiogenic Shock. Wiley-Blackwell. ISBN 9781405179263.
- ↑ 13.0 13.1 Svavarsdóttir AE, Jónasson MR, Gudmundsson GH, Fjeldsted K (June 1996). "Chest pain in family practice. Diagnosis and long-term outcome in a community setting". Can Fam Physician. 42: 1122–8. PMC 2146490. PMID 8704488.
- ↑ 14.0 14.1 Klinkman MS, Stevens D, Gorenflo DW (April 1994). "Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network". J Fam Pract. 38 (4): 345–52. PMID 8163958.
- ↑ 15.0 15.1 Bösner S, Becker A, Haasenritter J, Abu Hani M, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Seitz G, Baum E, Donner-Banzhoff N (2009). "Chest pain in primary care: epidemiology and pre-work-up probabilities". Eur J Gen Pract. 15 (3): 141–6. doi:10.3109/13814780903329528. PMID 19883149.
- ↑ 16.0 16.1 Ebell MH (March 2011). "Evaluation of chest pain in primary care patients". Am Fam Physician. 83 (5): 603–5. PMID 21391528.
- ↑ von Kodolitsch Y, Schwartz AG, Nienaber CA (October 2000). "Clinical prediction of acute aortic dissection". Arch. Intern. Med. 160 (19): 2977–82. PMID 11041906.
- ↑ 18.0 18.1 Pate JW, Walker WA, Cole FH, Owen EW, Johnson WH (May 1989). "Spontaneous rupture of the esophagus: a 30-year experience". Ann. Thorac. Surg. 47 (5): 689–92. PMID 2730190.
- ↑ Fleet RP, Dupuis G, Marchand A, Burelle D, Beitman BD (October 1994). "Panic disorder, chest pain and coronary artery disease: literature review". Can J Cardiol. 10 (8): 827–34. PMID 7954018.
- ↑ Bass C, Chambers JB, Kiff P, Cooper D, Gardner WN (December 1988). "Panic anxiety and hyperventilation in patients with chest pain: a controlled study". Q. J. Med. 69 (260): 949–59. PMID 3270082.
- ↑ Evans DW, Lum LC (January 1977). "Hyperventilation: An important cause of pseudoangina". Lancet. 1 (8004): 155–7. PMID 64694.
- ↑ Ros E, Armengol X, Grande L, Toledo-Pimentel V, Lacima G, Sanz G (July 1997). "Chest pain at rest in patients with coronary artery disease. Myocardial ischemia, esophageal dysfunction, or panic disorder?". Dig. Dis. Sci. 42 (7): 1344–53. PMID 9246027.
- ↑ Ben Freedman S, Tennant CC (April 1998). "Panic disorder and coronary artery spasm". Med. J. Aust. 168 (8): 376–7. PMID 9594945.
- ↑ Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, Sheps D (October 2007). "Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study". Arch. Gen. Psychiatry. 64 (10): 1153–60. doi:10.1001/archpsyc.64.10.1153. PMID 17909127.
- ↑ Mehta NJ, Khan IA (November 2002). "Cardiac Munchausen syndrome". Chest. 122 (5): 1649–53. PMID 12426266.
- ↑ Swap CJ, Nagurney JT (November 2005). "Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes". JAMA. 294 (20): 2623–9. doi:10.1001/jama.294.20.2623. PMID 16304077.
- ↑ Marcus GM, Cohen J, Varosy PD, Vessey J, Rose E, Massie BM, Chatterjee K, Waters D (January 2007). "The utility of gestures in patients with chest discomfort". Am. J. Med. 120 (1): 83–9. doi:10.1016/j.amjmed.2006.05.045. PMID 17208083.
- ↑ Verdon F, Burnand B, Herzig L, Junod M, Pécoud A, Favrat B (September 2007). "Chest wall syndrome among primary care patients: a cohort study". BMC Fam Pract. 8: 51. doi:10.1186/1471-2296-8-51. PMC 2072948. PMID 17850647.
- ↑ Davies HA, Jones DB, Rhodes J, Newcombe RG (December 1985). "Angina-like esophageal pain: differentiation from cardiac pain by history". J. Clin. Gastroenterol. 7 (6): 477–81. PMID 4086742.
- ↑ Panju AA, Hemmelgarn BR, Guyatt GH, Simel DL (October 1998). "The rational clinical examination. Is this patient having a myocardial infarction?". JAMA. 280 (14): 1256–63. PMID 9786377.
- ↑ Berger JP, Buclin T, Haller E, Van Melle G, Yersin B (March 1990). "Right arm involvement and pain extension can help to differentiate coronary diseases from chest pain of other origin: a prospective emergency ward study of 278 consecutive patients admitted for chest pain". J. Intern. Med. 227 (3): 165–72. PMID 2313224.
- ↑ Yelland MJ (September 2001). "Back, chest and abdominal pain. How good are spinal signs at identifying musculoskeletal causes of back, chest or abdominal pain?". Aust Fam Physician. 30 (9): 908–12. PMID 11676323.
- ↑ Chan S, Maurice AP, Davies SR, Walters DL (October 2014). "The use of gastrointestinal cocktail for differentiating gastro-oesophageal reflux disease and acute coronary syndrome in the emergency setting: a systematic review". Heart Lung Circ. 23 (10): 913–23. doi:10.1016/j.hlc.2014.03.030. PMID 24791662.
- ↑ Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Friedlander T, Bushnell AC, Chandra-Strobos N (December 2003). "Chest pain relief by nitroglycerin does not predict active coronary artery disease". Ann. Intern. Med. 139 (12): 979–86. PMID 14678917.
- ↑ Pryor DB, Harrell FE, Lee KL, Califf RM, Rosati RA (November 1983). "Estimating the likelihood of significant coronary artery disease". Am. J. Med. 75 (5): 771–80. PMID 6638047.
- ↑ Buntinx F, Knockaert D, Bruyninckx R, de Blaey N, Aerts M, Knottnerus JA, Delooz H (December 2001). "Chest pain in general practice or in the hospital emergency department: is it the same?". Fam Pract. 18 (6): 586–9. PMID 11739341.
- ↑ Tierney WM, Roth BJ, Psaty B, McHenry R, Fitzgerald J, Stump DL, Anderson FK, Ryder KW, McDonald CJ, Smith DM (July 1985). "Predictors of myocardial infarction in emergency room patients". Crit. Care Med. 13 (7): 526–31. PMID 4006491.
- ↑ Sequist TD, Marshall R, Lampert S, Buechler EJ, Lee TH (November 2006). "Missed opportunities in the primary care management of early acute ischemic heart disease". Arch. Intern. Med. 166 (20): 2237–43. doi:10.1001/archinte.166.20.2237. PMID 17101942.
- ↑ Norell M, Lythall D, Coghlan G, Cheng A, Kushwaha S, Swan J, Ilsley C, Mitchell A (January 1992). "Limited value of the resting electrocardiogram in assessing patients with recent onset chest pain: lessons from a chest pain clinic". Br Heart J. 67 (1): 53–6. PMC 1024701. PMID 1739527.
- ↑ Law K, Elley R, Tietjens J, Mann S (July 2006). "Troponin testing for chest pain in primary healthcare: a survey of its use by general practitioners in New Zealand". N. Z. Med. J. 119 (1238): U2082. PMID 16868579.
- ↑ Wilhelmsen L, Rosengren A, Hagman M, Lappas G (July 1998). ""Nonspecific" chest pain associated with high long-term mortality: results from the primary prevention study in Göteborg, Sweden". Clin Cardiol. 21 (7): 477–82. PMID 9669056.
- ↑ Ruigómez A, Rodríguez LA, Wallander MA, Johansson S, Jones R (April 2006). "Chest pain in general practice: incidence, comorbidity and mortality". Fam Pract. 23 (2): 167–74. doi:10.1093/fampra/cmi124. PMID 16461444.
- ↑ Robinson JG, Wallace R, Limacher M, Sato A, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG (December 2006). "Elderly women diagnosed with nonspecific chest pain may be at increased cardiovascular risk". J Womens Health (Larchmt). 15 (10): 1151–60. doi:10.1089/jwh.2006.15.1151. PMID 17199456.
- ↑ Geraldine McMahon C, Yates DW, Hollis S (February 2008). "Unexpected mortality in patients discharged from the emergency department following an episode of nontraumatic chest pain". Eur J Emerg Med. 15 (1): 3–8. doi:10.1097/MEJ.0b013e32827b14cd. PMID 18180659.
- ↑ Yelland M, Cayley WE, Vach W (March 2010). "An algorithm for the diagnosis and management of chest pain in primary care". Med. Clin. North Am. 94 (2): 349–74. doi:10.1016/j.mcna.2010.01.011. PMID 20380960.
- ↑ Wang WH, Huang JQ, Zheng GF, Wong WM, Lam SK, Karlberg J, Xia HH, Fass R, Wong BC (June 2005). "Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis". Arch. Intern. Med. 165 (11): 1222–8. doi:10.1001/archinte.165.11.1222. PMID 15956000.
- ↑ Borzecki AM, Pedrosa MC, Prashker MJ (March 2000). "Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis". Arch. Intern. Med. 160 (6): 844–52. PMID 10737285.
- ↑ Wertli MM, Ruchti KB, Steurer J, Held U (November 2013). "Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis". BMC Med. 11: 239. doi:10.1186/1741-7015-11-239. PMC 4226211. PMID 24207111.
- ↑ Takagi H, Ando T, Umemoto T (November 2017). "Meta-Analysis of Circadian Variation in the Onset of Acute Aortic Dissection". Am. J. Cardiol. 120 (9): 1662–1666. doi:10.1016/j.amjcard.2017.07.067. PMID 28847596.
- ↑ Kojima S, Sumiyoshi M, Nakata Y, Daida H (March 2002). "Triggers and circadian distribution of the onset of acute aortic dissection". Circ. J. 66 (3): 232–5. PMID 11922269.
- ↑ Eggebrecht, Holger; Baumgart, Dietrich; Schmermund, Axel; Herold, Ulf; Hunold, Peter; Jakob, Heinz; Erbel, Raimund (2003). "Penetrating atherosclerotic ulcer of the aorta: treatment by endovascular stent-graft placement". Current Opinion in Cardiology. 18 (6): 431–435. doi:10.1097/00001573-200311000-00002. ISSN 0268-4705.
- ↑ Bossone, Eduardo; LaBounty, Troy M; Eagle, Kim A (2018). "Acute aortic syndromes: diagnosis and management, an update". European Heart Journal. 39 (9): 739–749d. doi:10.1093/eurheartj/ehx319. ISSN 0195-668X.
- ↑ DeMartino, Randall R.; Sen, Indrani; Huang, Ying; Bower, Thomas C.; Oderich, Gustavo S.; Pochettino, Alberto; Greason, Kevin; Kalra, Manju; Johnstone, Jill; Shuja, Fahad; Harmsen, W. Scott; Macedo, Thanila; Mandrekar, Jay; Chamberlain, Alanna M.; Weiss, Salome; Goodney, Philip P.; Roger, Veronique (2018). "Population-Based Assessment of the Incidence of Aortic Dissection, Intramural Hematoma, and Penetrating Ulcer, and Its Associated Mortality From 1995 to 2015". Circulation: Cardiovascular Quality and Outcomes. 11 (8). doi:10.1161/CIRCOUTCOMES.118.004689. ISSN 1941-7713.
- ↑ Ewart W (March 1896). "Practical Aids in the Diagnosis of Pericardial Effusion, in Connection with the Question as to Surgical Treatment". Br Med J. 1 (1838): 717–21. PMC 2406464. PMID 20756103.
- ↑ Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristić AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W, Achenbach S, Agewall S, Al-Attar N, Angel Ferrer J, Arad M, Asteggiano R, Bueno H, Caforio AL, Carerj S, Ceconi C, Evangelista A, Flachskampf F, Giannakoulas G, Gielen S, Habib G, Kolh P, Lambrinou E, Lancellotti P, Lazaros G, Linhart A, Meurin P, Nieman K, Piepoli MF, Price S, Roos-Hesselink J, Roubille F, Ruschitzka F, Sagristà Sauleda J, Sousa-Uva M, Uwe Voigt J, Luis Zamorano J (November 2015). "2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)". Eur. Heart J. 36 (42): 2921–64. doi:10.1093/eurheartj/ehv318. PMID 26320112.
- ↑ Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA (April 1985). "Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome". N. Engl. J. Med. 312 (14): 885–90. doi:10.1056/NEJM198504043121404. PMID 3974674.
- ↑ Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L (June 2007). "A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis". Eur. Heart J. 28 (11): 1326–33. doi:10.1093/eurheartj/ehm076. PMID 17493945.
- ↑ Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Böhm M (April 2011). "Prognostic electrocardiographic parameters in patients with suspected myocarditis". Eur. J. Heart Fail. 13 (4): 398–405. doi:10.1093/eurjhf/hfq229. PMID 21239404.
- ↑ Elliott PM, Kaski JC, Prasad K, Seo H, Slade AK, Goldman JH, McKenna WJ (July 1996). "Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study". Eur. Heart J. 17 (7): 1056–64. PMID 8809524.
- ↑ Pasternac A, Noble J, Streulens Y, Elie R, Henschke C, Bourassa MG (April 1982). "Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries". Circulation. 65 (4): 778–89. PMID 7199403.
- ↑ Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED (January 1990). "Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates". J. Am. Coll. Cardiol. 15 (1): 83–90. PMID 2295747.
- ↑ Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ (February 2005). "Acute and reversible cardiomyopathy provoked by stress in women from the United States". Circulation. 111 (4): 472–9. doi:10.1161/01.CIR.0000153801.51470.EB. PMID 15687136.
- ↑ Krishnamoorthy P, Garg J, Sharma A, Palaniswamy C, Shah N, Lanier G, Patel NC, Lavie CJ, Ahmad H (July 2015). "Gender Differences and Predictors of Mortality in Takotsubo Cardiomyopathy: Analysis from the National Inpatient Sample 2009-2010 Database". Cardiology. 132 (2): 131–136. doi:10.1159/000430782. PMID 26159108.
- ↑ Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF (September 2015). "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy". N. Engl. J. Med. 373 (10): 929–38. doi:10.1056/NEJMoa1406761. PMID 26332547.
- ↑ Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS (December 2004). "Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction". Ann. Intern. Med. 141 (11): 858–65. PMID 15583228.
- ↑ Green SJ, Pizzarello RA, Padmanabhan VT, Ong LY, Hall MH, Tortolani AJ (April 1985). "Relation of angina pectoris to coronary artery disease in aortic valve stenosis". Am. J. Cardiol. 55 (8): 1063–5. PMID 3984868.
- ↑ Silaruks S, Clark D, Thinkhamrop B, Sia B, Buxton B, Tonkin A (2001). "Angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis". Heart Lung Circ. 10 (1): 14–23. doi:10.1046/j.1444-2892.2001.00060.x. PMID 16352020.
- ↑ Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M, Otto CM (February 1999). "Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome". Am. Heart J. 137 (2): 298–306. doi:10.1053/hj.1999.v137.95496. PMID 9924164.
- ↑ Anker SD, Sharma R (September 2002). "The syndrome of cardiac cachexia". Int. J. Cardiol. 85 (1): 51–66. PMID 12163209.
- ↑ Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (May 2008). "Albumin levels predict survival in patients with systolic heart failure". Am. Heart J. 155 (5): 883–9. doi:10.1016/j.ahj.2007.11.043. PMID 18440336.
- ↑ Breathett K, Allen LA, Udelson J, Davis G, Bristow M (October 2016). "Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction". Circ Heart Fail. 9 (10). doi:10.1161/CIRCHEARTFAILURE.115.002962. PMC 5082710. PMID 27656000.
- ↑ Stein PD, Beemath A, Matta F, Weg JG, Yusen RD, Hales CA, Hull RD, Leeper KV, Sostman HD, Tapson VF, Buckley JD, Gottschalk A, Goodman LR, Wakefied TW, Woodard PK (October 2007). "Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II". Am. J. Med. 120 (10): 871–9. doi:10.1016/j.amjmed.2007.03.024. PMC 2071924. PMID 17904458.
- ↑ "Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)". JAMA. 263 (20): 2753–9. 1990. PMID 2332918.
- ↑ Bense L, Wiman LG, Hedenstierna G (September 1987). "Onset of symptoms in spontaneous pneumothorax: correlations to physical activity". Eur J Respir Dis. 71 (3): 181–6. PMID 3678419.
- ↑ Seow A, Kazerooni EA, Pernicano PG, Neary M (February 1996). "Comparison of upright inspiratory and expiratory chest radiographs for detecting pneumothoraces". AJR Am J Roentgenol. 166 (2): 313–6. doi:10.2214/ajr.166.2.8553937. PMID 8553937.
- ↑ Stark P, Leung A (1996). "Effects of lobar atelectasis on the distribution of pleural effusion and pneumothorax". J Thorac Imaging. 11 (2): 145–9. PMID 8820023.
- ↑ Jalli R, Sefidbakht S, Jafari SH (April 2013). "Value of ultrasound in diagnosis of pneumothorax: a prospective study". Emerg Radiol. 20 (2): 131–4. doi:10.1007/s10140-012-1091-7. PMID 23179505.
- ↑ Feinsilver SH, Barrows AA, Braman SS (October 1986). "Fiberoptic bronchoscopy and pleural effusion of unknown origin". Chest. 90 (4): 516–9. PMID 3757561.
- ↑ Collins TR, Sahn SA (June 1987). "Thoracocentesis. Clinical value, complications, technical problems, and patient experience". Chest. 91 (6): 817–22. PMID 3581930.
- ↑ Venekamp LN, Velkeniers B, Noppen M (2005). "Does 'idiopathic pleuritis' exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy". Respiration. 72 (1): 74–8. doi:10.1159/000083404. PMID 15753638.
- ↑ Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B (March 1997). "Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease". Blood. 89 (5): 1787–92. PMID 9057664.
- ↑ Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS (July 1994). "The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease". Blood. 84 (2): 643–9. PMID 7517723.
- ↑ Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA (June 2000). "Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group". N. Engl. J. Med. 342 (25): 1855–65. doi:10.1056/NEJM200006223422502. PMID 10861320.
- ↑ Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (August 2006). "The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus". Am. J. Gastroenterol. 101 (8): 1900–20, quiz 1943. doi:10.1111/j.1572-0241.2006.00630.x. PMID 16928254.
- ↑ Vakil NB, Traxler B, Levine D (August 2004). "Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment". Clin. Gastroenterol. Hepatol. 2 (8): 665–8. PMID 15290658.
- ↑ Giannini EG, Zentilin P, Dulbecco P, Vigneri S, Scarlata P, Savarino V (February 2008). "Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment". Am. J. Gastroenterol. 103 (2): 267–75. doi:10.1111/j.1572-0241.2007.01659.x. PMID 18289194.
- ↑ Bott S, Prakash C, McCallum RW (August 1987). "Medication-induced esophageal injury: survey of the literature". Am. J. Gastroenterol. 82 (8): 758–63. PMID 3605035.
- ↑ Parfitt JR, Jayakumar S, Driman DK (September 2008). "Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes". Am. J. Surg. Pathol. 32 (9): 1367–72. PMID 18763324.
- ↑ Jaspersen D (March 2000). "Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management". Drug Saf. 22 (3): 237–49. PMID 10738847.
- ↑ Loyd JE, Tillman BF, Atkinson JB, Des Prez RM (September 1988). "Mediastinal fibrosis complicating histoplasmosis". Medicine (Baltimore). 67 (5): 295–310. PMID 3045478.
- ↑ Feigin DS, Eggleston JC, Siegelman SS (January 1979). "The multiple roentgen manifestations of sclerosing mediastinitis". Johns Hopkins Med J. 144 (1): 1–8. PMID 762913.
- ↑ Garrett HE, Roper CL (December 1986). "Surgical intervention in histoplasmosis". Ann. Thorac. Surg. 42 (6): 711–22. PMID 3539049.
- ↑ Sherrick AD, Brown LR, Harms GF, Myers JL (August 1994). "The radiographic findings of fibrosing mediastinitis". Chest. 106 (2): 484–9. PMID 7774324.
- ↑ Dickson AP, Imrie CW (October 1984). "The incidence and prognosis of body wall ecchymosis in acute pancreatitis". Surg Gynecol Obstet. 159 (4): 343–7. PMID 6237447.
- ↑ Yadav D, Agarwal N, Pitchumoni CS (June 2002). "A critical evaluation of laboratory tests in acute pancreatitis". Am. J. Gastroenterol. 97 (6): 1309–18. doi:10.1111/j.1572-0241.2002.05766.x. PMID 12094843.
- ↑ Fortson MR, Freedman SN, Webster PD (December 1995). "Clinical assessment of hyperlipidemic pancreatitis". Am. J. Gastroenterol. 90 (12): 2134–9. PMID 8540502.
- ↑ Lecesne R, Taourel P, Bret PM, Atri M, Reinhold C (June 1999). "Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome". Radiology. 211 (3): 727–35. doi:10.1148/radiology.211.3.r99jn08727. PMID 10352598.
- ↑ Stimac D, Miletić D, Radić M, Krznarić I, Mazur-Grbac M, Perković D, Milić S, Golubović V (May 2007). "The role of nonenhanced magnetic resonance imaging in the early assessment of acute pancreatitis". Am. J. Gastroenterol. 102 (5): 997–1004. doi:10.1111/j.1572-0241.2007.01164.x. PMID 17378903.